EB
At a glance
Registered since
2024
Senate LDA system
Clients
1
last 3 years
Filings
3
2 agencies contacted
Activity
filings by quarter
Works on
Background
Government experience
Internship for Rep. Mike Rogers (R-MI).
Disclosed on LD-2 filings
Career
EI
Specific issues
General issues related to Medicare and Medicaid, including: Part D Medicare Program; Part B Medicare Program; Drug Pricing; Centers for Medicare and Medicaid Services (CMS) National Coverage Determination NCD for Alzheimer's Drugs; H.R.5376, Inflation Reduction Act of 2022 (P.L.117-169) implementation; Center for Medicare and Medicaid Innovation (CMMI) Proposed Accelerated Approval Payment Policy; Center for Medicare and Medicaid Innovation (CMMI) Medicaid Proposed Rebate Rule; S. 2379 / H.R. 4752, the CHANGE Act. Issues related to intellectual property.
Issues related to tax reform.
Regulatory and legislative health care issues, including: Alzheimer's drug development; Drug Pricing; H.R.5378, Lower Costs, More Transparency Act; S.3430, Better Mental Health Care Lower-Cost Drugs and Health Extenders Act; S.2973, Modernizing and Ensuring PBM Accountability Act; improvements to the 340B drug discount program; Seniors Access to Critical Medications Act of 2023.; S. 4276 / H.R. 7688, the Accelerating Access to Dementia & Alzheimers Provider Training (AADAPT) Act.
General issues related to Medicare and Medicaid, Part D Medicare Program, Part B Medicare Program; Drug Pricing; Centers for Medicare and Medicaid Services (CMS) National Coverage Determination (NCD) for Alzheimers Drugs; H.R. 5376, Inflation Reduction Act of 2022 (PL 117-169) implementation; Center for Medicare and Medicaid Innovation (CMMI) Proposed Accelerated Approval Payment Policy; Center for Medicare and Medicaid Innovation (CMMI) Proposed Rebate Rule.
Issues related to R&D tax credit; H.R.7024, Tax Relief for American Families and Workers Act of 2024.
Regulatory and legislative health care issues, including: Alzheimer's drug development; Drug Pricing; H.R.5378, Lower Costs, More Transparency Act; Pandemic and All-Hazards Preparedness Act (PAHPA) including reauthorizing priority review vouchers; S.3430, Better Mental Health Care Lower-Cost Drugs and Health Extenders Act; S.2973, Modernizing and Ensuring Pharmacy Benefit Managers (PBM) Accountability Act; H.R.2882, Further Consolidated Appropriations Act, 2024, P.L.118-47;improvements to the 340B drug discount program; Seniors Access to Critical Medications Act of 2023.